Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 076643
Company: RANBAXY
Company: RANBAXY
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CARBILEV | CARBIDOPA; LEVODOPA | 10MG;100MG | TABLET, FOR SUSPENSION;ORAL | Discontinued | None | No | No |
CARBILEV | CARBIDOPA; LEVODOPA | 25MG;100MG | TABLET, FOR SUSPENSION;ORAL | Discontinued | None | No | No |
CARBILEV | CARBIDOPA; LEVODOPA | 25MG;250MG | TABLET, FOR SUSPENSION;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/10/2005 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/076643ltr.pdf |